Medical Oncologist
Your treatment timeline
How Long Will You Stay on — Alectinib?
Alectinib is not given in a set number of cycles. It continues for as long as it is controlling your cancer and you can tolerate it — and the scans, not a calendar, are what decide when that changes.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- No fixed finish date — Alectinib is not given in cycles with a planned end. It continues for as long as it is working and tolerable.
- Scans decide, not a calendar — The main signal to stop is disease progression on imaging, not a course length.
- Side effects rarely mean stopping — A dose reduction or a short break is usually tried before stopping treatment altogether.
- There is a plan for what comes next — Resistance to alectinib is expected eventually. Later-line ALK inhibitors and chemotherapy are established options.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Alectinib has no fixed course. You take it for as long as it controls your cancer and you can tolerate it. NCCN and ASCO guidelines describe it as continuous therapy — stopped only when scans show disease progression or when side effects become unmanageable despite a dose adjustment.
Why does alectinib not have a set end date?
Alectinib works differently from chemotherapy. Chemotherapy is given in cycles with a planned finish because cumulative doses become harmful. Alectinib targets the specific ALK protein driving your cancer, and as long as your cancer still depends on that signal, the drug keeps working.
Because it is taken as a daily capsule at home, the aim is continuous suppression rather than a short intensive course. There is no final cycle — treatment continues until the biology changes.
That answer can feel unsettling when you are used to treatments with a known end date. For patients whose cancer responds, data from the ALEX trial reported in the New England Journal of Medicine showed the drug can hold the disease for a substantial period — years in a proportion of patients.
What will stop your alectinib treatment?
- Disease progression on a CT scanThe cancer has grown or new lesions have appeared since your last comparison scan.
- A side effect that cannot be controlledWhen a dose reduction and a short break do not resolve the problem, stopping may be recommended.
- A significant decline in general fitnessIf continuing treatment puts you at greater risk than it is likely to benefit you.
- A more appropriate next treatmentA clinical trial or a later-generation drug that fits your situation better may prompt a planned switch.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What does regular monitoring look like on alectinib?
Baseline assessment before you start
Scans and blood tests establish your starting point. Every future comparison is made against these.
Blood tests at each visit
Liver enzymes, kidney function, and creatine phosphokinase are monitored because alectinib can affect them. Your team adjusts the dose if levels change.
CT scans at planned intervals
Each scan is compared against your baseline to assess whether the cancer is responding, stable, or changing.
Clinical review at each appointment
Your oncologist reviews results, asks about symptoms, and decides whether to continue at the same dose or make a change.
If a scan shows the cancer has changed
Your team will explain what they see and discuss what comes next — closer monitoring, a biopsy, or a change in treatment.
What happens when alectinib eventually stops working?
Alectinib eventually stops working in most patients. The cancer develops a new mutation that lets it bypass the ALK signal the drug is blocking — a process called acquired resistance.
When that happens, treatment options remain. NCCN guidance includes lorlatinib, a third-generation ALK inhibitor, as a recommended later-line option for many patients who have progressed on alectinib. Chemotherapy and clinical trials are also established paths.
Your oncologist may recommend a repeat biopsy or liquid biopsy at this point to identify the resistance mutation, because knowing the specific change can help guide what to try next.
Did you know?
The ALEX trial, published in the New England Journal of Medicine in 2017, showed that patients on alectinib went significantly longer before their disease progressed than those on crizotinib, the previous standard.
That result changed international guidelines. Alectinib is now the preferred first-line choice in NCCN, ASCO, and ESMO guidance for ALK-positive lung cancer.
Source: Solomon et al., ALEX trial, New England Journal of Medicine, 2017
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
What does it mean when a scan shows progression?
Progression means the CT scan shows the cancer has grown since the last comparison point, or that new areas have appeared. This is the main signal your team uses to judge whether alectinib is still controlling the disease. A single scan result is not always acted on immediately — your oncologist will look at the rate of change and your symptoms alongside the images before deciding whether to stop or switch.
Can the dose of alectinib be reduced instead of stopping?
Yes. A dose reduction is usually the first step when side effects become difficult to manage — for things like muscle pain, fluid retention, or liver enzyme changes. Stopping is not the default response to a side effect. Your team may reduce the dose, pause treatment briefly, or add medication to manage the problem. The aim is to keep you on alectinib for as long as it is working.
Can I take a break from alectinib?
Short treatment breaks are sometimes needed for a procedure, a serious side effect, or to let your body recover. A planned pause does not automatically mean the cancer will immediately worsen, but your team will monitor you closely during any time off. Stopping for reasons other than a medical need is something to discuss first — your oncologist can explain what the evidence says about gaps in continuous therapy for ALK-positive lung cancer.
How will I know if alectinib is working?
The main measure is CT scans. A response shows as the tumour shrinking or staying stable in size. Your symptoms may also improve — less breathlessness, less cough, more energy — though symptoms do not always track exactly with what the scan shows. Your team will explain what each scan result means and what they are watching for at the next review.
What comes after alectinib if it stops working?
Lorlatinib is the most commonly recommended next-line ALK inhibitor in NCCN guidance for patients who have progressed on alectinib. Chemotherapy, particularly platinum-based regimens, is also an established option. A repeat biopsy may be recommended to identify the resistance mechanism, which can help guide the choice. Your oncologist will explain which of these fits your situation.
Does insurance or a patient support programme cover alectinib?
Alectinib is approved by CDSCO in India, and coverage through insurance or government schemes varies by policy. If cost is a concern, raise it with your CION team early — the manufacturer operates a patient access programme that may be available to you, and your team can help you explore what options exist before you start rather than after.